Waiting game continues. While they’ve made some inroads on debt management and operating expenses. It won’t be anywhere near enough but appreciate them showing diligence. It’s what we’ve all known for some time now, that it all still hinges on the Pulse. First clues will be how many of the15,000 strong waitlist actually purchase a Pulse. And if the revenue is enough to stem the flow. Marketing approach also seems more targeted which is encouraging.
My gut feel is early pulse revenue probably isn’t enough to be profitable initially. Which I’m actually ok with if it stems the bleeding and prevents any need for further capital. The Pulse will need time to get a foot in the market from which to build from. Seems to be some breadcrumbs to suggest positive signs ahead, but who really knows. Next few months will be fun.
CDX Price at posting:
5.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)